HELION BIOTECH ApS
Credit rating
Company information
About HELION BIOTECH ApS
HELION BIOTECH ApS (CVR number: 31758106) is a company from KØBENHAVN. The company recorded a gross profit of 25.7 kDKK in 2023. The operating profit was -65.2 kDKK, while net earnings were -48.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -19.2 %, which can be considered poor and Return on Equity (ROE) was -22.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 77 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. HELION BIOTECH ApS's liquidity measured by quick ratio was 4.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -18.09 | 34.10 | 54.80 | 33.21 | 25.70 |
EBIT | -18.09 | 34.10 | 17.45 | 33.21 | -65.18 |
Net earnings | -22.79 | 28.19 | 11.21 | 21.56 | -48.17 |
Shareholders equity total | 180.64 | 208.83 | 220.03 | 241.59 | 193.43 |
Balance sheet total (assets) | 575.80 | 534.98 | 455.65 | 415.24 | 251.05 |
Net debt | - 488.28 | - 430.51 | - 312.11 | - 279.62 | - 217.96 |
Profitability | |||||
EBIT-% | |||||
ROA | -2.1 % | 6.1 % | 3.5 % | 7.7 % | -19.2 % |
ROE | -6.1 % | 14.5 % | 5.2 % | 9.3 % | -22.1 % |
ROI | -4.8 % | 16.5 % | 7.4 % | 12.3 % | -24.9 % |
Economic value added (EVA) | 9.20 | 46.89 | 25.09 | 33.25 | -40.65 |
Solvency | |||||
Equity ratio | 85.1 % | 79.7 % | 80.5 % | 74.7 % | 77.0 % |
Gearing | 5.7 % | 4.9 % | 11.0 % | 16.3 % | 12.4 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 16.4 | 9.1 | 7.9 | 4.9 | 4.4 |
Current ratio | 1.3 | 1.4 | 1.6 | 2.1 | 4.4 |
Cash and cash equivalents | 498.61 | 440.83 | 336.33 | 319.04 | 242.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | B | BB | BB | BB | C |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.